$IBTA

Leach Bryan sold $486K of IBTA

Leach Bryan (CEO AND PRESIDENT) sold 15,154 shares of Ibotta, Inc. (IBTA) at an average of $32.07 ($31.96–$32.82, $0.49M total) across 3 trades over 2026-06-08 to 2026-06-09 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Leach Bryan
Published Jun 10, 2026, 8:17 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 10, 2026, 8:22 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$IBTA
Neutral
high confidence
Mentioned
$IBTA
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$IBTANeutralLow
01

Why it matters

The newest concrete fact is the CEO/President’s open-market sale amount, timing, and confirmation that it was executed under a pre-arranged 10b5-1 plan.

02

Market read

Traders may note the disclosed insider sale, but the 10b5-1 framing makes it more of a sentiment footnote than a tradable fundamental catalyst.

03

What to watch

The article doesn’t state whether sales were part of a broader planned schedule (beyond 10b5-1) or whether there were concurrent buys, limiting inference.

Relevance 3/10Novelty 2/10Timing: Filed 2026-06-10; trades executed 2026-06-08 to 2026-06-09.

Background

The article is an SEC EDGAR Form 4 insider transaction disclosure for Ibotta, Inc. (IBTA).

Company-level read

Ticker impact

$IBTANeutralHigh confidence
Context

SEC Form 4 shows CEO/President Leach Bryan sold 15,154 IBTA shares for ~$485,988 under a pre-arranged 10b5-1 plan (6/8–6/9).

Expected impact

Low near-term impact; any reaction is likely muted and short-lived given the disclosed 10b5-1 plan.

Evidence & confidence

The filing is a primary-source insider transaction, but the article specifies it was executed under a pre-arranged 10b5-1 plan, reducing interpretive weight versus discretionary selling.

Market effects

No sector-level implications; this is company-specific insider liquidity activity.

None indicated.

None indicated.

Counterpoint

Even with 10b5-1, repeated insider selling can still coincide with near-term risk perception; traders may watch for follow-on selling or other disclosures.

Key entities

  • Ibotta, Inc.

    Subject of the Form 4 insider transaction disclosure (IBTA).

  • Leach Bryan

    CEO and President; sold 15,154 shares under a pre-arranged 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$IBTAMedAI 8/10

Ibotta (IBTA) Q2 2026 Earnings Call Transcript

Ibotta (IBTA) reported Q2 2026 revenue of $88.9 million, up 3% year over year, and adjusted EBITDA of $16.5 million. Third-party redemption revenue rose 27% to $61.5 million as the company shifted users to its publisher network. Q3 revenue guidance is $86 million to $90 million. Ibotta also said it added 11,500 7-Eleven locations via a partnership.

$IBTAMed

Ibotta, Inc. (IBTA): Results of Operations and Financial Condition

Ibotta, Inc. (IBTA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Ibotta Reports Second Quarter 2026 Financial Results Ibotta’s second quarter financial results exceeded the upper end of the guidance range for both revenue and adjusted EBITDA Revenue grew by 3% year-over-year to $88.9 million Redemption revenue grew by 10% year-over-year to $80